Abstract Title:

IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5.

Abstract Source:

Genes Immun. 2007 Sep ;8(6):503-12. Epub 2007 Jul 19. PMID: 17641683

Abstract Author(s):

J-H Shin, M Janer, B McNeney, S Blay, K Deutsch, C B Sanjeevi, I Kockum, A Lernmark, J Graham, , , Hans Arnqvist, Elizabeth Björck, Jan Eriksson, Lennarth Nyström, Lars Olof Ohlson, Bengt Scherstén, Jan Ostman, M Aili, L E Bååth, E Carlsson, H Edenwall, G Forsander, B W Granström, I Gustavsson, R Hanås, L Hellenberg, H Hellgren, E Holmberg, H Hörnell, Sten-A Ivarsson, C Johansson, G Jonsell, K Kockum, B Lindblad, A Lindh, J Ludvigsson, U Myrdal, J Neiderud, K Segnestam, S Sjöblad, L Skogsberg, L Strömberg, U Ståhle, B Thalme, K Tullus, T Tuvemo, M Wallensteen, O Westphal, J Aman

Article Affiliation:

Department of Statistics and Actuarial Science, Simon Fraser University, Burnaby, British Columbia, Canada.


In a large case-control study of Swedish incident type I diabetes patients and controls, 0-34 years of age, we tested the hypothesis that the GIMAP5 gene, a key genetic factor for lymphopenia in spontaneous BioBreeding rat diabetes, is associated with type I diabetes; with islet autoantibodies in incident type I diabetes patients or with age at clinical onset in incident type I diabetes patients. Initial scans of allelic association were followed by more detailed logistic regression modeling that adjusted for known type I diabetes risk factors and potential confounding variables. The single nucleotide polymorphism (SNP) rs6598, located in a polyadenylation signal of GIMAP5, was associated with the presence of significant levels of IA-2 autoantibodies in the type I diabetes patients. Patients with the minor allele A of rs6598 had an increased prevalence of IA-2 autoantibody levels compared to patients without the minor allele (OR=2.2; Bonferroni-corrected P=0.003), after adjusting for age at clinical onset (P=8.0 x 10(-13)) and the numbers of HLA-DQ A1*0501-B1*0201 haplotypes (P=2.4 x 10(-5)) and DQ A1*0301-B1*0302 haplotypes (P=0.002). GIMAP5 polymorphism was not associated with type I diabetes or with GAD65 or insulin autoantibodies, ICA, or age at clinical onset in patients. These data suggest that the GIMAP5 gene is associated with islet autoimmunity in type I diabetes and add to recent findings implicating the same SNP in another autoimmune disease.

Study Type : Human Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.